港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

信达生物

40.250

-10.000-19.90%

成交量：3,229.15万

成交额：13.58亿

市值：659.30亿

市盈率：-651.62

高：44.550

开：42.800

低：40.000

收：50.250

数据加载中...

总览公司新闻公告

信达生物IBI354 (创新型HER2 ADC) 治疗铂耐药卵巢癌的III期临床研究完成首例受试者给药

信达生物(01801)癌症新药拟纳入突破性治疗品种

信达生物03月21日主力净流出3012万元散户资金买入

信达生物涨超4% 信必敏完成首批发货公司与美年健康集团达成战略合作

AI赋能+创新药双驱动！美年健康携手信达生物，积极响应国家“体重管理年”健康行动

信达生物，稳了？

和黄医药(00013)与信达生物宣布呋喹替尼 (fruquintinib) 联合信迪利单抗 (sintilimab) 用于治疗晚期肾细胞癌的FRUSICA-2中国II/III期研究达到主要终点

信达生物03月18日获主力加仓4589万元

AI 赋能+政策支持，港股创新药迎来“黄金布局期”

信达生物(01801)启动玛仕度肽VS司美格鲁肽治疗代谢相关脂肪性肝病III期临床

智通财经网

信达生物启动玛仕度肽VS司美格鲁肽治疗代谢相关脂肪性肝病III期临床

《股市简讯》中国信达生物一度涨2.3%，国家药监局批准其眼病药物上市

21健讯Daily | 信达生物抗体新药在中国获批上市；白云山归母净利润同比下降30.09%

21世纪经济报道

信达生物IGF-1R抗体药物获批

信达生物(01801)：IGF-1R单抗信必敏获批用于治疗甲状腺眼病

中国首个IGF-1R单抗：信达生物信必敏®获批，填补甲状腺眼病治疗空白

信达生物(01801)：中国首个IGF-1R单抗信必敏®获国家药监局批准上市用于治疗甲状腺眼病

信达生物(01801.HK)治疗甲状腺眼病药物获准中国上市

阿斯达克财经

信达生物盘中异动股价大涨5.09%

前信达生物总裁刘勇军透露新动向，低调创业只做自免领域，还给字节跳动当顾问

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/01801/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01801","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01801\",,,,,undefined,":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"信达生物","latestPrice":40.25,"timestamp":1744003710141,"preClose":50.25,"halted":0,"volume":32291475,"delay":0,"floatShares":1638000000,"shares":1638000000,"eps":-0.061768663020679584,"marketStatus":"交易中","change":-10,"latestTime":"04-07 13:28:30","open":42.8,"high":44.55,"low":40,"amount":1358360191,"amplitude":0.090547,"askPrice":40.25,"askSize":500,"bidPrice":40.2,"bidSize":17000,"shortable":3,"etf":0,"ttmEps":-0.06373817255255348,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1744013400000},"marketStatusCode":2,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":50.25,"openAndCloseTimeList":[[1743989400000,1743998400000],[1744002000000,1744012800000]],"volumeRatio":1.975975,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.8279,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01801\",,,,,undefined,":{"symbol":"01801","floatShares":1638000000,"roa":"-2.24%","roe":"-0.74%","lyrEps":-0.061769,"volumeRatio":1.975975,"shares":1638000000,"dividePrice":0,"high":44.55,"amplitude":0.090547,"preClose":50.25,"low":40,"week52Low":28.65,"pbRate":"4.73","psRate":"6.59","week52High":52.15,"institutionHeld":0,"latestPrice":40.25,"committee":0.942857,"eps":-0.061768663020679584,"divideRate":0,"volume":32291475,"delay":0,"ttmEps":-0.06373817255255348,"open":42.8,"prevYearClose":36.6,"prevWeekClose":50.25,"prevMonthClose":46.6,"prevQuarterClose":46.6,"fiveDayClose":46.2,"twentyDayClose":40.2,"sixtyDayClose":35.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01801\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521771068","title":"信达生物IBI354 (创新型HER2 ADC) 治疗铂耐药卵巢癌的III期临床研究完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2521771068","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521771068?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 08:00","pubTimestamp":1742774400,"startTime":"0","endTime":"0","summary":"同时，IBI354治疗展现出明显优于其它ADC的优秀临床安全性和治疗耐受性。\" 信达生物制药集团高级副总裁周辉博士表示：\"很高兴IBI354在HER2表达的铂耐药卵巢癌的临床III期研究完成首例受试者首次给药，也十分期待IBI354获得积极结果，为HER2表达的铂耐药卵巢癌患者提供更理想的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4647606_ZH47606_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2488822045.USD","BK1161","BK4231","IVBIY","BK4139","ADC","BK4134","BK1583","BK1589","BK4080","LU1969619763.USD","LU2328871848.SGD","01801","III"],"gpt_icon":0},{"id":"2521232242","title":"信达生物(01801)癌症新药拟纳入突破性治疗品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2521232242","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521232242?lang=zh_cn&edition=fundamental","pubTime":"2025-03-23 08:26","pubTimestamp":1742689575,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月21日，中国国家药监局药品审评中心官网最新公示，信达生物申报的1类新药IBI363拟纳入突破性治疗品种，用于既往未经过系统性治疗的不可切除局部晚期或转移性肢端型及黏膜型恶性黑色素瘤。针对本次拟纳入突破性治疗品种的适应症，信达生物已经于今年3月初启动IBI363的关键注册研究，同时这也是IBI363的首个关键注册临床研究。根据信达生物此前新闻稿，IBI363在前期研究中已在未经免疫治疗的黑色素瘤上展现出了突破性疗效信号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"信达生物(01801)癌症新药拟纳入突破性治疗品种","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1583","LU2328871848.SGD","BK1161","LU1969619763.USD","LU2488822045.USD","01801"],"gpt_icon":1},{"id":"2521447470","title":"信达生物03月21日主力净流出3012万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2521447470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521447470?lang=zh_cn&edition=fundamental","pubTime":"2025-03-21 16:16","pubTimestamp":1742544981,"startTime":"0","endTime":"0","summary":"03月21日, 信达生物股价跌6.02%，报收40.60元，成交金额6.30亿元，换手率0.93%，振幅6.94%，量比0.98。信达生物今日主力资金净流出3012万元，上一交易日主力净流入2640万元。该股近5个交易日上涨0.49%，主力资金累计净流入8710万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入680万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250321170338a69eae07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250321170338a69eae07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","LU2328871848.SGD","LU1969619763.USD","BK1161","BK1589","BK1583","LU2488822045.USD"],"gpt_icon":0},{"id":"2520034221","title":"信达生物涨超4% 信必敏 完成首批发货 公司与美年健康集团达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2520034221","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520034221?lang=zh_cn&edition=fundamental","pubTime":"2025-03-20 14:10","pubTimestamp":1742451008,"startTime":"0","endTime":"0","summary":"信达生物涨超4%，截至发稿，涨4.08%，报43.4港元，成交额5.12亿港元。消息面上，信达生物今早宣布，信必敏已经完成首批发货，并陆续抵达全国药房。据悉，信必敏是信达生物第15款产品，是中国首个、全球第二款IGF-1R单抗药物，是中国唯一获批能够逆转甲状腺突眼的无创突破性疗法。此外，3月18日，信达生物与美年健康集团达成深度战略合作。据悉，玛仕度肽是全球首个申报上市的GCG/GLP-1双靶药物，玛仕度肽减重适应症预计今年获批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320142441a69d2201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320142441a69d2201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","LU1969619763.USD","LU2328871848.SGD","LU2488822045.USD","01801","BK1589"],"gpt_icon":0},{"id":"2520630171","title":"AI赋能+创新药双驱动！美年健康携手信达生物，积极响应国家“体重管理年”健康行动","url":"https://stock-news.laohu8.com/highlight/detail?id=2520630171","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520630171?lang=zh_cn&edition=fundamental","pubTime":"2025-03-20 13:22","pubTimestamp":1742448120,"startTime":"0","endTime":"0","summary":"3月18日，美年健康集团与信达生物达成深度战略合作，双方将整合优势资源，聚焦超重合并脂肪肝客户的精准干预，为代谢性疾病防治探索创新模式，助力公众健康管理。美年健康与信达生物也迅速行动，发挥各自优势，以“降脂”和“科学减重”为关键切入点，携手共同推动科学减重。如今，信达生物已经成为中国肿瘤治疗领域领军品牌，并持续加大在慢病管理领域的布局。该药将于今年上市，惠及广大用户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-20/doc-ineqhrzq3874731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","002044","LU1969619763.USD","BK0196","BK1574","BK0236","BK0077","LU2097828805.USD","01801","LU2097828631.EUR","06978","BK0146","LU2097828557.USD","LU2097828714.EUR","LU2488822045.USD","BK0028","LU2328871848.SGD","LU2097828474.EUR","BK1589","BK1583","159992","BK0114"],"gpt_icon":0},{"id":"2520351112","title":"信达生物，稳了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2520351112","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520351112?lang=zh_cn&edition=fundamental","pubTime":"2025-03-20 08:05","pubTimestamp":1742429100,"startTime":"0","endTime":"0","summary":"自2020年获批贝伐珠单抗、利妥昔单抗、阿达木单抗3款生物类似药后，信达已全面加码创新药研发，这几年获批上市的全部是创新药。这是国内多数药企受困于生存问题时，信达生物的营收仍逐年增长、且利润亏损呈收窄之势的重要原因。礼来财报显示，2024年信迪利单抗销售额达38亿元，占同期信达产品总收入82亿元的比重高达46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320080657971cd53d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320080657971cd53d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","LU1969619763.USD","LU2488822045.USD","BK1161","LU2328871848.SGD","01801"],"gpt_icon":0},{"id":"2520879968","title":"和黄医药(00013)与信达生物宣布呋喹替尼 (fruquintinib) 联合信迪利单抗 (sintilimab) 用于治疗晚期肾细胞癌的FRUSICA-2中国II/III期研究达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2520879968","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520879968?lang=zh_cn&edition=fundamental","pubTime":"2025-03-19 08:10","pubTimestamp":1742343054,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药 发布公告，和黄医药(中国)有限公司和信达生物制药集团今日联合宣布呋喹替尼 和信迪利单抗 联合疗法用于二线治疗局部晚期或转移性肾细胞癌的FRUSICA-2中国II/III期研究已达到盲态独立中心阅片根据 RECIST 1.1标准评估的无进展生存期的主要终点。FRUSICA-2研究是一项随机、开放标签、阳性对照的临床试验，旨在评估呋喹替尼和信迪利单抗联合疗法对比阿昔替尼或依维莫司单药疗法用于二线治疗晚期肾细胞癌的疗效和安全性  。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1263795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","LU1969619763.USD","BK4531","HCM","III","BK1583","BK1588","BK1589","BK1191","BK4134","BK4007","BK4588","BK4585","LU2488822045.USD","01801","00013","LU2328871848.SGD","BK1161"],"gpt_icon":1},{"id":"2520928614","title":"信达生物03月18日获主力加仓4589万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2520928614","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520928614?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 16:15","pubTimestamp":1742285749,"startTime":"0","endTime":"0","summary":"03月18日, 信达生物股价涨1.87%，报收40.80元，成交金额5.20亿元，换手率0.77%，振幅3.62%，量比1.19。信达生物今日主力资金净流入4589万元，连续3日净流入，上一交易日主力净流入144万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为47.06%，平均涨幅为2.84%。该股近5个交易日上涨3.02%，主力资金累计净流入4715万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入8156万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318165030a69a51cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318165030a69a51cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","LU2488822045.USD","BK1161","BK1583","01801","LU2328871848.SGD","LU1969619763.USD"],"gpt_icon":0},{"id":"2520667747","title":"AI 赋能+政策支持，港股创新药迎来“黄金布局期”","url":"https://stock-news.laohu8.com/highlight/detail?id=2520667747","media":"万家基金","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520667747?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 11:27","pubTimestamp":1742268442,"startTime":"0","endTime":"0","summary":"据报道，医疗卫生军团将重点构建AI辅助诊断解决方案体系，推动医疗大模型在临床场景的应用。受AI热潮催化、政策利好不断等因素影响，近来创新药市场的增长势头良好，港股创新药板块的表现也较为强劲。AI 赋能是创新药的另一大看点。AI通过强大的计算能力和数据处理能力，可以加速药物研发，降低研发成本，有助于缩短新药上市时间，还能提高新药的成功率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318112520a699ef16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318112520a699ef16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","01177","02607","00867","01548","06127","06185","01558","06821","02359","06978","02269","HSTECH","09969","BK1587","03692","09688","01513","02196","09926","HSCEI","09995","01801","00512","BK1574","00013","BK1191","02096","01093","03347","01877","03759","BK1161","02268","06160","02186","01530"],"gpt_icon":1},{"id":"2520248225","title":"信达生物(01801)启动玛仕度肽VS司美格鲁肽治疗代谢相关脂肪性肝病III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2520248225","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520248225?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 21:24","pubTimestamp":1742217842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月14日，药物临床试验登记与信息公示平台显示，信达启动了一项在中国超重或肥胖合并代谢相关脂肪性肝病受试者中比较玛仕度肽与司美格鲁肽有效性和安全性的多中心、随机、开放标签的III期临床研究。目前，玛仕度肽在中国超重或肥胖受试者和2型糖尿病受试者中的多项III期临床研究正在进行中。其中， GLORY-1和DREAMS-2研究已经达成主要终点。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1263067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","BK4134","BK4085","VS","BK1161","III","LU1969619763.USD","LU2328871848.SGD","LU2488822045.USD","01801","BK1589"],"gpt_icon":0},{"id":"2520240185","title":"信达生物启动玛仕度肽VS司美格鲁肽治疗代谢相关脂肪性肝病III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2520240185","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520240185?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 21:24","pubTimestamp":1742217842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月14日，药物临床试验登记与信息公示平台显示，信达启动了一项在中国超重或肥胖合并代谢相关脂肪性肝病受试者中比较玛仕度肽与司美格鲁肽有效性和安全性的多中心、随机、开放标签的III期临床研究。目前，玛仕度肽在中国超重或肥胖受试者和2型糖尿病受试者中的多项III期临床研究正在进行中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503172128409719b178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503172128409719b178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2328871848.SGD","LU1969619763.USD","BK1583","LU2488822045.USD","BK1589","01801"],"gpt_icon":0},{"id":"2520689563","title":"《股市简讯》中国信达生物一度涨2.3%，国家药监局批准其眼病药物上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2520689563","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520689563?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 13:07","pubTimestamp":1742188054,"startTime":"0","endTime":"0","summary":"《股市简讯》中国信达生物一度涨2.3%，国家药监局批准其眼病药物上市* 中国生物科技公司信达生物1801.HK周一盘中一度升2.3%。* 该公司此前公告称，信必敏的新药上市申请获中国国家药品监督管理局批准上市，用于治疗甲状腺眼病。这是一种器官特异自身免疫性疾病，引起眼球突出、复视等临床表现，严重的可导致失明。* 信达生物今年迄今涨11.9%，同期恒生指数.HSI上扬21%。* 恒生香港上市生物科技指数.HSHKBIO盘中一度升1.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL4S3Q00AQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU2328871848.SGD","LU2488822045.USD","BK1589","LU1969619763.USD","BK1583","BK1161"],"gpt_icon":0},{"id":"2520539311","title":"21健讯Daily | 信达生物抗体新药在中国获批上市；白云山归母净利润同比下降30.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2520539311","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520539311?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 08:53","pubTimestamp":1742172792,"startTime":"0","endTime":"0","summary":"政策动向中国疾病预防控制中心主任调整日前，中国疾病预防控制中心（中国预防医学科学院）召开干部大会。根据决定，王健伟同志任中国疾病预防控制中心（中国预防医学科学院）主任（院长）、党委副书记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503173347067759.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503173347067759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00874","01801"],"gpt_icon":0},{"id":"2519088875","title":"信达生物IGF-1R抗体药物获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2519088875","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519088875?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 17:39","pubTimestamp":1741945169,"startTime":"0","endTime":"0","summary":"3月14日，信达生物（01801）发布公告，宣布其研发的IGF-1R抗体信必敏?（替妥尤单抗N01注射液）已获得中国国家药品监督管理局的批准，用于治疗甲状腺眼病。这是中国首个获批的IGF-1R抗体药物，也是全球第二款，标志着该公司在重大疾病治疗领域的又一里程碑。该药物的安全性良好，能够显著改善患者的炎症和生活质量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503143346198629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","IGF","BK1583","LU1969619763.USD","LU2328871848.SGD","BK1589","01801","LU2488822045.USD"],"gpt_icon":0},{"id":"2519821970","title":"信达生物(01801)：IGF-1R单抗信必敏获批用于治疗甲状腺眼病","url":"https://stock-news.laohu8.com/highlight/detail?id=2519821970","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519821970?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 16:36","pubTimestamp":1741941392,"startTime":"0","endTime":"0","summary":"金吾财讯 | 信达生物(01801)宣布，重组抗胰岛素样生长因子1受体（“IGF-1R”）抗体信必敏（替妥尤单抗N01注射液）的新药上市申请（“NDA”）获中国国家药品监督管理局（“NMPA”）批准上市，用于治疗甲状腺眼病(Thyroid Eye Disease,TED)。信必敏是中国首个、全球第二款获批的IGF-1R抗体药物，也是中国甲状腺眼病治疗领域70年来的首款新药，将重塑甲状腺眼病的治疗标准。甲状腺眼病是与甲状腺疾病密切相关的一种器官特异自身免疫性疾病，位居成人眼眶疾病发病率首位，在40-60岁年龄段尤其高发。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/NzJkY2Y1NGFiZmJjZmI1MTMzYzFhNzg2YjE4NjgwNzc5NTAwMDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NzJkY2Y1NGFiZmJjZmI1MTMzYzFhNzg2YjE4NjgwNzc5NTAwMDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1955101","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU2328871848.SGD","BK1161","LU1969619763.USD","BK1589","IGF","BK1583","LU2488822045.USD"],"gpt_icon":0},{"id":"2519356777","title":"中国首个IGF-1R单抗：信达生物信必敏®获批，填补甲状腺眼病治疗空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2519356777","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519356777?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 16:35","pubTimestamp":1741941300,"startTime":"0","endTime":"0","summary":"信必敏是中国首个、全球第二款获批的IGF-1R抗体药物，也是中国甲状腺眼病治疗领域70年来的首款新药，将重塑甲状腺眼病的治疗标准。信必敏作为中国首个获批的IGF-1R抗体，疗效优异，安全性良好，为甲状腺眼病患者带来了全新可及的治疗选择，具有重要的临床及社会价值。2025年3月，信必敏获中国国家药品监督管理局批准用于治疗甲状腺眼病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4641219_ZH41219_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1161","LU1969619763.USD","LU2488822045.USD","01801","BK1589","LU2328871848.SGD","BK1583","IVBIY","BK4139","IGF"],"gpt_icon":0},{"id":"2519982929","title":"信达生物(01801)：中国首个IGF-1R单抗信必敏®获国家药监局批准上市用于治疗甲状腺眼病","url":"https://stock-news.laohu8.com/highlight/detail?id=2519982929","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519982929?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 16:34","pubTimestamp":1741941253,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信达生物 发布公告，重组抗胰岛素样生长因子1受体抗体信必敏 的新药上市申请获中国国家药品监督管理局批准上市，用于治疗甲状腺眼病。信必敏是中国首个、全球第二款获批的IGF-1R抗体药物，也是中国甲状腺眼病治疗领域70年来的首款新药，将重塑甲状腺眼病的治疗标准。信必敏作为中国首个获批的IGF-1R抗体，疗效优异，安全性良好，为甲状腺眼病患者带来了全新可及的治疗选择，具有重要的临床及社会价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1261945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1589","LU1969619763.USD","LU2488822045.USD","BK1161","IGF","LU2328871848.SGD","01801"],"gpt_icon":0},{"id":"2519829174","title":"信达生物(01801.HK)治疗甲状腺眼病药物获准中国上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2519829174","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519829174?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 16:31","pubTimestamp":1741941060,"startTime":"0","endTime":"0","summary":"信达生物(01801.HK) 公布，重组抗胰岛素样生长因子1受体抗体信必敏的新药上市申请，获中国国家药品监督管理局批准上市，用于治疗甲状腺眼病。公告指，信必敏是中国首个、全球第二款获批的IGF-1R抗体药物，也是中国甲状腺眼病治疗领域七十年来的首款新药，将重塑甲状腺眼病的治疗标准。(js/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-14 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220906114108815_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220906114108815_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1424756/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1589","BK1583","LU2328871848.SGD","BK1161","LU1969619763.USD","LU2488822045.USD","01801"],"gpt_icon":0},{"id":"2519842788","title":"信达生物盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519842788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519842788?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 14:54","pubTimestamp":1741935292,"startTime":"0","endTime":"0","summary":"2025年03月14日下午盘14时54分，信达生物股票出现异动，股价急速上涨5.09%。截至发稿，该股报41.300港元/股，成交量1060.18万股，换手率0.65%，振幅5.85%。信达生物股票所在的药品行业中，整体涨幅为0.54%。其相关个股中，李氏大药厂、君圣泰医药-B、顺腾国际控股涨幅较大，振幅较大的相关个股有君圣泰医药-B、九源基因、康龙化成，振幅分别为10.91%、9.59%、9.09%。信达生物公司简介：信达生物制药是一家从事药物研发、生产及销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314145452a1dc4dd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314145452a1dc4dd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","BK1161","BK1583","LU2488822045.USD","BK1589","LU1969619763.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2519813264","title":"前信达生物总裁刘勇军透露新动向，低调创业只做自免领域，还给字节跳动当顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=2519813264","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519813264?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 09:42","pubTimestamp":1741916577,"startTime":"0","endTime":"0","summary":"3月13日，刘勇军以小路生物创始人、吉林大学唐敖庆客座教授的身份，现身易贸医疗举办的BIOCHINA会议现场。另据刘勇军透露，目前他还在给字节跳动当顾问，“字节跳动也在做药”。“小路生物只做自免领域，这是我最熟悉的，而且公司规模不会超过20人。小路生物招的都是非常年轻的科学家。”刘勇军在上述会议上透露。作为前信达生物总裁，刘勇军的动向颇受业内关注。刘勇军身上有着诸多光环。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503143345673252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2488822045.USD","01801","LU1969619763.USD","BK1583","LU2328871848.SGD","BK1589","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01801\",params:#limit:5,,,undefined,":[{"date":"2025-03-26","symbol":"01801","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盘后","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-28","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-20","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710898200000,"name":null,"time":"","dateTimestamp":1710864000000,"actualEps":null},{"date":"2023-08-23","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692754200000,"name":null,"time":"","dateTimestamp":1692720000000,"actualEps":null},{"date":"2023-03-28","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679967000000,"name":null,"time":"","dateTimestamp":1679932800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01801\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01801\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3462,"buy":0.5769,"hold":0.0385,"sell":0.0385,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5769,"analysts":26,"updateTime":1743609600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01801\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01801","date":"2025-04-03","current":-812.530138,"percent":0,"low":-812.530138,"twenty":-57.971959,"median":-42.563523,"eighty":-19.437399,"high":-7.531991,"avg":-45.183233,"sd":48.861706,"marketCap":82318922076},"quantilePoints":[{"date":"2020-04-09","current":-24.212626,"twenty":-6.482664,"median":-5.554756,"eighty":-5.177825,"marketCap":45844435621},{"date":"2020-04-17","current":-23.755693,"twenty":-6.645159,"median":-5.589224,"eighty":-5.18918,"marketCap":44770481053},{"date":"2020-04-24","current":-26.421678,"twenty":-22.636151,"median":-5.635457,"eighty":-5.190101,"marketCap":49737520930},{"date":"2020-04-29","current":-27.365329,"twenty":-23.338114,"median":-5.848132,"eighty":-5.254528,"marketCap":51549819264},{"date":"2020-05-08","current":-27.178649,"twenty":-23.758502,"median":-5.948307,"eighty":-5.310499,"marketCap":51224508961},{"date":"2020-05-15","current":-30.791169,"twenty":-24.182984,"median":-5.973731,"eighty":-5.324838,"marketCap":57803803690},{"date":"2020-05-22","current":-29.168327,"twenty":-25.034777,"median":-6.103124,"eighty":-5.341371,"marketCap":54581291986},{"date":"2020-05-29","current":-30.400474,"twenty":-26.331676,"median":-6.21517,"eighty":-5.369798,"marketCap":56796768783},{"date":"2020-06-05","current":-33.076663,"twenty":-27.433485,"median":-6.370676,"eighty":-5.389498,"marketCap":62247271783},{"date":"2020-06-12","current":-33.900554,"twenty":-28.047312,"median":-6.480797,"eighty":-5.399506,"marketCap":63791702475},{"date":"2020-06-19","current":-35.263657,"twenty":-29.291259,"median":-6.564073,"eighty":-5.407402,"marketCap":66477668895},{"date":"2020-06-26","current":-42.782564,"twenty":-30.461342,"median":-6.742053,"eighty":-5.416549,"marketCap":80578992600},{"date":"2020-07-03","current":-42.15165,"twenty":-31.212367,"median":-21.5439,"eighty":-5.426457,"marketCap":79513042032},{"date":"2020-07-10","current":-41.718218,"twenty":-33.055097,"median":-23.009394,"eighty":-5.428958,"marketCap":79445885746},{"date":"2020-07-17","current":-36.617176,"twenty":-33.853843,"median":-23.56045,"eighty":-5.435413,"marketCap":69842536920},{"date":"2020-07-24","current":-35.392158,"twenty":-34.117248,"median":-23.759204,"eighty":-5.43938,"marketCap":67241749424},{"date":"2020-07-31","current":-34.790809,"twenty":-34.526864,"median":-24.13478,"eighty":-5.448361,"marketCap":66487246107},{"date":"2020-08-07","current":-36.619021,"twenty":-34.926791,"median":-24.303633,"eighty":-5.465712,"marketCap":70056561424},{"date":"2020-08-14","current":-36.782836,"twenty":-35.235669,"median":-24.961961,"eighty":-5.472343,"marketCap":70546467448},{"date":"2020-08-21","current":-40.576246,"twenty":-35.792876,"median":-25.584933,"eighty":-5.486343,"marketCap":78175004107},{"date":"2020-08-28","current":-43.795492,"twenty":-36.439174,"median":-26.421678,"eighty":-5.520251,"marketCap":79784695329},{"date":"2020-09-04","current":-39.665739,"twenty":-36.777743,"median":-27.271989,"eighty":-5.526185,"marketCap":72506091544},{"date":"2020-09-11","current":-42.988967,"twenty":-37.537428,"median":-27.599103,"eighty":-5.541887,"marketCap":78664910131},{"date":"2020-09-18","current":-47.462616,"twenty":-38.638915,"median":-28.066584,"eighty":-5.578764,"marketCap":87693178287},{"date":"2020-09-25","current":-44.177192,"twenty":-39.337069,"median":-29.168327,"eighty":-5.58909,"marketCap":80974467101},{"date":"2020-09-30","current":-43.635669,"twenty":-39.577106,"median":-29.30153,"eighty":-5.589358,"marketCap":80363386427},{"date":"2020-10-09","current":-45.526878,"twenty":-40.068119,"median":-30.400474,"eighty":-5.594485,"marketCap":85053584067},{"date":"2020-10-16","current":-50.643672,"twenty":-40.933846,"median":-30.680202,"eighty":-5.627514,"marketCap":94573985247},{"date":"2020-10-23","current":-47.907898,"twenty":-41.325791,"median":-32.326031,"eighty":-5.801767,"marketCap":89603775808},{"date":"2020-10-30","current":-42.811074,"twenty":-41.735504,"median":-32.968835,"eighty":-5.84909,"marketCap":80083374628},{"date":"2020-11-06","current":-42.967789,"twenty":-42.743927,"median":-33.29142,"eighty":-5.864706,"marketCap":81316323725},{"date":"2020-11-13","current":-40.934902,"twenty":-42.378258,"median":-33.900554,"eighty":-5.91801,"marketCap":77534169133},{"date":"2020-11-20","current":-41.561739,"twenty":-42.114631,"median":-34.056118,"eighty":-5.952614,"marketCap":79215126730},{"date":"2020-11-27","current":-38.270387,"twenty":-41.89284,"median":-34.145822,"eighty":-5.961576,"marketCap":72771455944},{"date":"2020-12-04","current":-42.094411,"twenty":-41.89284,"median":-34.507897,"eighty":-5.975351,"marketCap":80618802227},{"date":"2020-12-11","current":-41.498839,"twenty":-41.89284,"median":-34.562136,"eighty":-6.024626,"marketCap":79287996630},{"date":"2020-12-18","current":-49.483759,"twenty":-42.135729,"median":-34.875798,"eighty":-6.083138,"marketCap":94697324597},{"date":"2020-12-24","current":-53.344979,"twenty":-42.79967,"median":-35.04397,"eighty":-6.115628,"marketCap":102191861381},{"date":"2020-12-31","current":-60.05736,"twenty":-43.169204,"median":-35.327908,"eighty":-6.141418,"marketCap":115097770553},{"date":"2021-01-08","current":-59.811501,"twenty":-59.909844,"median":-58.854704,"eighty":-57.04374,"marketCap":115658880952},{"date":"2021-01-15","current":-65.889833,"twenty":-65.542577,"median":-59.934431,"eighty":-58.653787,"marketCap":127231897878},{"date":"2021-01-22","current":-75.111578,"twenty":-69.798545,"median":-61.62536,"eighty":-58.836696,"marketCap":144977859301},{"date":"2021-01-29","current":-66.268267,"twenty":-70.935369,"median":-65.600453,"eighty":-58.920414,"marketCap":128966248334},{"date":"2021-02-05","current":-70.843724,"twenty":-71.160691,"median":-66.402516,"eighty":-59.472589,"marketCap":137044833867},{"date":"2021-02-11","current":-73.259421,"twenty":-72.388775,"median":-68.623378,"eighty":-59.909845,"marketCap":141921097207},{"date":"2021-02-19","current":-69.584878,"twenty":-72.910639,"median":-69.283721,"eighty":-60.353226,"marketCap":134861432372},{"date":"2021-02-26","current":-60.141164,"twenty":-72.481128,"median":-68.087003,"eighty":-60.420269,"marketCap":116302519660},{"date":"2021-03-05","current":-56.85889,"twenty":-72.0166,"median":-66.268267,"eighty":-60.074121,"marketCap":109679535123},{"date":"2021-03-12","current":-59.415349,"twenty":-71.520469,"median":-65.634307,"eighty":-59.099919,"marketCap":114410238364},{"date":"2021-03-19","current":-58.603337,"twenty":-71.014965,"median":-65.279781,"eighty":-58.980041,"marketCap":112809077267},{"date":"2021-03-26","current":-57.420101,"twenty":-70.801528,"median":-63.675052,"eighty":-58.456619,"marketCap":110043435373},{"date":"2021-04-01","current":-99.513447,"twenty":-72.111714,"median":-65.255751,"eighty":-58.603337,"marketCap":117685340607},{"date":"2021-04-09","current":-93.829103,"twenty":-73.100725,"median":-65.311073,"eighty":-58.727146,"marketCap":111207916170},{"date":"2021-04-16","current":-91.762285,"twenty":-74.85113,"median":-65.783649,"eighty":-58.836696,"marketCap":109170074775},{"date":"2021-04-23","current":-109.839824,"twenty":-90.431092,"median":-66.402516,"eighty":-58.920414,"marketCap":131004089730},{"date":"2021-04-30","current":-102.619464,"twenty":-91.452277,"median":-68.724058,"eighty":-59.011683,"marketCap":122897013046},{"date":"2021-05-07","current":-97.428671,"twenty":-96.409896,"median":-69.352117,"eighty":-59.213107,"marketCap":117436541495},{"date":"2021-05-14","current":-101.964808,"twenty":-97.632955,"median":-70.026533,"eighty":-59.379727,"marketCap":122824206759},{"date":"2021-05-21","current":-109.973218,"twenty":-99.103595,"median":-70.738235,"eighty":-59.57381,"marketCap":132507442977},{"date":"2021-05-28","current":-107.105119,"twenty":-100.222008,"median":-71.636143,"eighty":-59.909845,"marketCap":130323254356},{"date":"2021-06-04","current":-106.183195,"twenty":-103.047548,"median":-72.784205,"eighty":-60.090882,"marketCap":128588964422},{"date":"2021-06-11","current":-108.23655,"twenty":-104.283306,"median":-74.011578,"eighty":-60.308104,"marketCap":131066032292},{"date":"2021-06-18","current":-104.996815,"twenty":-104.950024,"median":-74.677498,"eighty":-60.754148,"marketCap":126111896552},{"date":"2021-06-25","current":-108.401163,"twenty":-105.285659,"median":-75.279371,"eighty":-61.553193,"marketCap":130118918107},{"date":"2021-07-02","current":-106.622678,"twenty":-106.183195,"median":-90.445668,"eighty":-61.619211,"marketCap":127760482537},{"date":"2021-07-09","current":-100.272231,"twenty":-106.183195,"median":-90.948745,"eighty":-61.62536,"marketCap":120030681653},{"date":"2021-07-16","current":-106.975494,"twenty":-106.622678,"median":-92.795694,"eighty":-61.712678,"marketCap":128052173136},{"date":"2021-07-23","current":-102.477274,"twenty":-106.622678,"median":-96.369361,"eighty":-62.277177,"marketCap":122655897047},{"date":"2021-07-30","current":-96.244101,"twenty":-106.531079,"median":-96.160202,"eighty":-62.43474,"marketCap":115582400012},{"date":"2021-08-06","current":-90.456671,"twenty":-106.183195,"median":-96.076303,"eighty":-63.026939,"marketCap":108369781827},{"date":"2021-08-13","current":-89.117798,"twenty":-106.148472,"median":-94.251891,"eighty":-64.323165,"marketCap":106911238330},{"date":"2021-08-20","current":-76.56893,"twenty":-106.141613,"median":-92.830432,"eighty":-65.231721,"marketCap":91596531611},{"date":"2021-08-27","current":-52.912902,"twenty":-105.631697,"median":-91.452399,"eighty":-63.026939,"marketCap":88752371792},{"date":"2021-09-03","current":-57.411891,"twenty":-105.383527,"median":-90.623704,"eighty":-61.62536,"marketCap":96337788726},{"date":"2021-09-10","current":-55.660683,"twenty":-105.292659,"median":-90.464692,"eighty":-60.141164,"marketCap":93639455507},{"date":"2021-09-17","current":-57.825782,"twenty":-105.258722,"median":-90.168186,"eighty":-59.326295,"marketCap":96994140050},{"date":"2021-09-24","current":-63.057451,"twenty":-105.257871,"median":-87.790274,"eighty":-59.397538,"marketCap":105818418957},{"date":"2021-09-30","current":-65.454027,"twenty":-105.205276,"median":-86.731586,"eighty":-59.427942,"marketCap":110207765023},{"date":"2021-10-08","current":-65.977203,"twenty":-105.066231,"median":-82.434007,"eighty":-59.619544,"marketCap":111083588321},{"date":"2021-10-15","current":-66.495128,"twenty":-104.917441,"median":-78.481513,"eighty":-59.76961,"marketCap":112032396894},{"date":"2021-10-22","current":-65.935102,"twenty":-104.784173,"median":-75.402004,"eighty":-59.909845,"marketCap":111886426345},{"date":"2021-10-29","current":-60.1915,"twenty":-104.573848,"median":-74.894538,"eighty":-59.969027,"marketCap":101887443690},{"date":"2021-11-05","current":-59.419571,"twenty":-104.241823,"median":-74.011578,"eighty":-59.426278,"marketCap":100746520293},{"date":"2021-11-12","current":-64.535702,"twenty":-104.144247,"median":-72.784205,"eighty":-59.558476,"marketCap":109872110899},{"date":"2021-11-19","current":-68.964255,"twenty":-103.89668,"median":-71.636143,"eighty":-59.76961,"marketCap":117245588109},{"date":"2021-11-26","current":-63.104,"twenty":-103.574286,"median":-70.738235,"eighty":-59.868596,"marketCap":107316945529},{"date":"2021-12-03","current":-56.970022,"twenty":-103.502791,"median":-69.584878,"eighty":-59.426278,"marketCap":97064410689},{"date":"2021-12-10","current":-56.787261,"twenty":-103.406584,"median":-69.317919,"eighty":-59.328306,"marketCap":96918229348},{"date":"2021-12-17","current":-46.241205,"twenty":-103.373136,"median":-68.872296,"eighty":-58.827693,"marketCap":78864833685},{"date":"2021-12-24","current":-42.300946,"twenty":-103.099197,"median":-68.604599,"eighty":-58.435519,"marketCap":72213582651},{"date":"2021-12-31","current":-41.234857,"twenty":-102.722762,"median":-67.767406,"eighty":-58.065904,"marketCap":70546743038},{"date":"2022-01-07","current":-34.486195,"twenty":-40.275969,"median":-37.64864,"eighty":-34.378339,"marketCap":58776768292},{"date":"2022-01-14","current":-37.878055,"twenty":-39.829817,"median":-37.763347,"eighty":-34.687526,"marketCap":64698308382},{"date":"2022-01-21","current":-35.699125,"twenty":-39.504145,"median":-36.722111,"eighty":-34.943651,"marketCap":61116142155},{"date":"2022-01-28","current":-26.329119,"twenty":-38.684591,"median":-35.628932,"eighty":-34.378339,"marketCap":44959841418},{"date":"2022-02-04","current":-26.846632,"twenty":-38.167145,"median":-35.414472,"eighty":-33.988231,"marketCap":45821080875},{"date":"2022-02-11","current":-27.092592,"twenty":-37.878055,"median":-35.02492,"eighty":-28.311865,"marketCap":46334276980},{"date":"2022-02-18","current":-29.050449,"twenty":-37.64864,"median":-34.653971,"eighty":-28.311865,"marketCap":49926649721},{"date":"2022-02-25","current":-29.744971,"twenty":-36.735769,"median":-33.988231,"eighty":-27.979692,"marketCap":51246296850},{"date":"2022-03-04","current":-27.223879,"twenty":-36.722111,"median":-29.802166,"eighty":-27.979692,"marketCap":46920786816},{"date":"2022-03-11","current":-23.132687,"twenty":-36.621639,"median":-29.36929,"eighty":-27.223879,"marketCap":39809355064},{"date":"2022-03-18","current":-23.353608,"twenty":-35.699125,"median":-29.07698,"eighty":-26.329119,"marketCap":40029296252},{"date":"2022-03-25","current":-23.609253,"twenty":-35.558739,"median":-28.622989,"eighty":-24.861144,"marketCap":40469178628},{"date":"2022-04-01","current":-10.302966,"twenty":-35.270205,"median":-28.485417,"eighty":-23.573298,"marketCap":39809355064},{"date":"2022-04-08","current":-10.829548,"twenty":-35.143591,"median":-28.187716,"eighty":-23.264469,"marketCap":41862139487},{"date":"2022-04-14","current":-10.543533,"twenty":-35.059727,"median":-27.88961,"eighty":-22.413734,"marketCap":40689119817},{"date":"2022-04-22","current":-10.163583,"twenty":-34.960508,"median":-27.608169,"eighty":-14.664685,"marketCap":38489707935},{"date":"2022-04-29","current":-9.896969,"twenty":-34.847033,"median":-27.171587,"eighty":-10.835566,"marketCap":36876805888},{"date":"2022-05-06","current":-7.794072,"twenty":-34.754637,"median":-27.092592,"eighty":-10.351079,"marketCap":28800028988},{"date":"2022-05-13","current":-7.531991,"twenty":-34.486195,"median":-26.329119,"eighty":-10.163583,"marketCap":27333632400},{"date":"2022-05-20","current":-9.06555,"twenty":-34.216555,"median":-24.981857,"eighty":-9.94212,"marketCap":33360522377},{"date":"2022-05-27","current":-8.694531,"twenty":-33.988231,"median":-24.386135,"eighty":-9.493302,"marketCap":31967445618},{"date":"2022-06-02","current":-9.642455,"twenty":-32.008842,"median":-23.573298,"eighty":-9.445349,"marketCap":35642983659},{"date":"2022-06-10","current":-10.68648,"twenty":-30.190287,"median":-23.325512,"eighty":-9.612624,"marketCap":39236617814},{"date":"2022-06-17","current":-10.7582,"twenty":-29.767849,"median":-23.119688,"eighty":-9.67054,"marketCap":39456636231},{"date":"2022-06-24","current":-14.400248,"twenty":-29.698416,"median":-20.893648,"eighty":-9.677673,"marketCap":53024438653},{"date":"2022-06-30","current":-13.932533,"twenty":-29.496285,"median":-17.024829,"eighty":-9.74948,"marketCap":51213898589},{"date":"2022-07-08","current":-14.67593,"twenty":-29.3239,"median":-15.17553,"eighty":-9.857114,"marketCap":54002047796},{"date":"2022-07-15","current":-14.83334,"twenty":-29.179562,"median":-14.952896,"eighty":-9.904546,"marketCap":54075420144},{"date":"2022-07-22","current":-14.019077,"twenty":-29.071673,"median":-14.83334,"eighty":-9.929111,"marketCap":51140526242},{"date":"2022-07-29","current":-13.158261,"twenty":-28.820464,"median":-14.63277,"eighty":-9.965579,"marketCap":48058887645},{"date":"2022-08-05","current":-14.452099,"twenty":-28.640649,"median":-14.521363,"eighty":-10.047766,"marketCap":52650020045},{"date":"2022-08-12","current":-14.71463,"twenty":-28.603223,"median":-14.534456,"eighty":-10.093451,"marketCap":53679489711},{"date":"2022-08-19","current":-14.001057,"twenty":-28.570837,"median":-14.521363,"eighty":-10.095676,"marketCap":50565103155},{"date":"2022-08-26","current":-15.136454,"twenty":-28.470894,"median":-14.486731,"eighty":-10.136779,"marketCap":53314867072},{"date":"2022-09-02","current":-13.75829,"twenty":-28.35224,"median":-14.400248,"eighty":-10.174316,"marketCap":48286589223},{"date":"2022-09-09","current":-12.67453,"twenty":-28.162886,"median":-14.340141,"eighty":-10.188715,"marketCap":44313642009},{"date":"2022-09-16","current":-11.97665,"twenty":-28.030016,"median":-14.29062,"eighty":-10.196162,"marketCap":41486737260},{"date":"2022-09-23","current":-10.816798,"twenty":-27.907626,"median":-14.221409,"eighty":-10.24124,"marketCap":36749761735},{"date":"2022-09-30","current":-10.989799,"twenty":-27.744526,"median":-14.086255,"eighty":-10.312544,"marketCap":37408857483},{"date":"2022-10-07","current":-10.967956,"twenty":-27.640481,"median":-14.000529,"eighty":-10.336741,"marketCap":37332356752},{"date":"2022-10-14","current":-11.448997,"twenty":-27.488229,"median":-13.89571,"eighty":-10.263806,"marketCap":38556368449},{"date":"2022-10-21","current":-13.815232,"twenty":-27.213421,"median":-13.759398,"eighty":-10.307755,"marketCap":46206441554},{"date":"2022-10-28","current":-12.395469,"twenty":-27.165938,"median":-13.60575,"eighty":-10.336584,"marketCap":41386895498},{"date":"2022-11-04","current":-14.340639,"twenty":-27.133191,"median":-13.618391,"eighty":-10.375435,"marketCap":48347495967},{"date":"2022-11-11","current":-14.799648,"twenty":-27.0434,"median":-13.75829,"eighty":-10.403849,"marketCap":50339627338},{"date":"2022-11-18","current":-14.669694,"twenty":-26.743129,"median":-13.855471,"eighty":-10.5207,"marketCap":49726663840},{"date":"2022-11-25","current":-12.759206,"twenty":-26.31944,"median":-13.760506,"eighty":-10.550481,"marketCap":42907444916},{"date":"2022-12-02","current":-12.446274,"twenty":-26.045094,"median":-13.719165,"eighty":-10.589876,"marketCap":42577469882},{"date":"2022-12-09","current":-14.33147,"twenty":-25.054285,"median":-13.649228,"eighty":-10.646322,"marketCap":49481924457},{"date":"2022-12-16","current":-14.387249,"twenty":-24.801403,"median":-13.759398,"eighty":-10.697091,"marketCap":49558640619},{"date":"2022-12-23","current":-14.560885,"twenty":-24.527177,"median":-13.788181,"eighty":-10.74327,"marketCap":50172369915},{"date":"2022-12-30","current":-14.738058,"twenty":-24.421396,"median":-13.826106,"eighty":-10.754467,"marketCap":51399828506},{"date":"2023-01-06","current":-14.850279,"twenty":-23.920006,"median":-13.912069,"eighty":-10.764544,"marketCap":52323278120},{"date":"2023-01-13","current":-18.011522,"twenty":-23.58768,"median":-13.988706,"eighty":-10.797588,"marketCap":64675254333},{"date":"2023-01-20","current":-18.576885,"twenty":-23.451175,"median":-14.010067,"eighty":-10.824448,"marketCap":66132940967},{"date":"2023-01-27","current":-20.253712,"twenty":-23.369759,"median":-14.086255,"eighty":-10.829548,"marketCap":72117128201},{"date":"2023-02-03","current":-19.550889,"twenty":-23.353608,"median":-14.221409,"eighty":-10.844594,"marketCap":69975086836},{"date":"2023-02-10","current":-18.461328,"twenty":-23.297415,"median":-14.245235,"eighty":-10.967956,"marketCap":65678370978},{"date":"2023-02-17","current":-17.287694,"twenty":-23.132687,"median":-14.283163,"eighty":-10.989799,"marketCap":60921292706},{"date":"2023-02-24","current":-16.928562,"twenty":-23.119688,"median":-14.316312,"eighty":-11.024034,"marketCap":58926388915},{"date":"2023-03-03","current":-18.506493,"twenty":-22.859931,"median":-14.340639,"eighty":-11.034338,"marketCap":64834373220},{"date":"2023-03-10","current":-17.143751,"twenty":-18.007033,"median":-17.594016,"eighty":-17.406062,"marketCap":59616932535},{"date":"2023-03-17","current":-18.225066,"twenty":-64.535702,"median":-27.223879,"eighty":-8.33302,"marketCap":63990375462},{"date":"2023-03-24","current":-16.635504,"twenty":-64.428087,"median":-27.157464,"eighty":-8.3397,"marketCap":59079843053},{"date":"2023-03-31","current":-21.665543,"twenty":-64.392731,"median":-27.092592,"eighty":-8.34275,"marketCap":53939129436},{"date":"2023-04-06","current":-23.653196,"twenty":-64.390621,"median":-26.634155,"eighty":-8.352405,"marketCap":58849661846},{"date":"2023-04-14","current":-26.320033,"twenty":-64.362795,"median":-26.324576,"eighty":-8.358879,"marketCap":65549469340},{"date":"2023-04-21","current":-23.835896,"twenty":-64.30121,"median":-26.271674,"eighty":-8.365503,"marketCap":59332248009},{"date":"2023-04-28","current":-23.269102,"twenty":-64.264448,"median":-25.584933,"eighty":-8.381733,"marketCap":57490108356},{"date":"2023-05-05","current":-25.40213,"twenty":-64.226366,"median":-25.443671,"eighty":-8.392457,"marketCap":62863015679},{"date":"2023-05-12","current":-24.841882,"twenty":-63.995645,"median":-25.285405,"eighty":-8.397793,"marketCap":61053226682},{"date":"2023-05-19","current":-24.150302,"twenty":-63.567828,"median":-25.133368,"eighty":-8.401129,"marketCap":58518941801},{"date":"2023-05-25","current":-24.040915,"twenty":-63.478503,"median":-25.133368,"eighty":-8.403051,"marketCap":57981366220},{"date":"2023-06-02","current":-23.630086,"twenty":-63.473336,"median":-25.04176,"eighty":-8.412356,"marketCap":56829418547},{"date":"2023-06-09","current":-24.154309,"twenty":-63.449017,"median":-24.911552,"eighty":-8.424162,"marketCap":58006344624},{"date":"2023-06-16","current":-23.65814,"twenty":-63.399642,"median":-24.844401,"eighty":-8.424971,"marketCap":56542705118},{"date":"2023-06-23","current":-19.736815,"twenty":-63.261636,"median":-24.800239,"eighty":-8.430589,"marketCap":46913497843},{"date":"2023-06-30","current":-19.361003,"twenty":-63.08538,"median":-24.583422,"eighty":-8.44223,"marketCap":45603925654},{"date":"2023-07-07","current":-19.824835,"twenty":-63.045246,"median":-24.39464,"eighty":-8.448328,"marketCap":46605363211},{"date":"2023-07-14","current":-20.972988,"twenty":-63.025798,"median":-24.281068,"eighty":-8.448858,"marketCap":49996366985},{"date":"2023-07-21","current":-21.298184,"twenty":-63.023861,"median":-24.205923,"eighty":-8.451759,"marketCap":50535619017},{"date":"2023-07-28","current":-23.791121,"twenty":-62.900857,"median":-24.161547,"eighty":-8.45846,"marketCap":56390355367},{"date":"2023-08-04","current":-21.285622,"twenty":-62.621827,"median":-24.152023,"eighty":-8.468652,"marketCap":50535619017},{"date":"2023-08-11","current":-21.635252,"twenty":-62.473049,"median":-24.087847,"eighty":-8.483716,"marketCap":51075672185},{"date":"2023-08-18","current":-20.673771,"twenty":-62.457914,"median":-23.929713,"eighty":-8.495975,"marketCap":48456406945},{"date":"2023-08-25","current":-35.378703,"twenty":-62.412077,"median":-24.023529,"eighty":-8.502433,"marketCap":52077155954},{"date":"2023-09-01","current":-36.587783,"twenty":-62.312576,"median":-24.142541,"eighty":-8.513294,"marketCap":54080524613},{"date":"2023-09-08","current":-37.287346,"twenty":-62.243984,"median":-24.154309,"eighty":-8.541071,"marketCap":54465713535},{"date":"2023-09-15","current":-41.061694,"twenty":-62.09617,"median":-24.166632,"eighty":-8.556024,"marketCap":60443963680},{"date":"2023-09-22","current":-41.150073,"twenty":-62.027557,"median":-24.212626,"eighty":-8.57503,"marketCap":60309214704},{"date":"2023-09-29","current":-41.957156,"twenty":-61.990984,"median":-24.362375,"eighty":-8.585232,"marketCap":61597529037},{"date":"2023-10-06","current":-42.818398,"twenty":-61.979722,"median":-24.399805,"eighty":-8.60704,"marketCap":62831819583},{"date":"2023-10-13","current":-48.929979,"twenty":-61.964165,"median":-24.604406,"eighty":-8.63324,"marketCap":71692717216},{"date":"2023-10-20","current":-48.564987,"twenty":-61.809044,"median":-24.821061,"eighty":-8.647132,"marketCap":71048288297},{"date":"2023-10-27","current":-49.577379,"twenty":-61.731951,"median":-24.852773,"eighty":-8.67951,"marketCap":72498253365},{"date":"2023-11-03","current":-50.935903,"twenty":-61.695214,"median":-24.911552,"eighty":-8.688438,"marketCap":74682635412},{"date":"2023-11-10","current":-51.497919,"twenty":-61.695214,"median":-24.911552,"eighty":-8.688438,"marketCap":75490889042},{"date":"2023-11-17","current":-48.797205,"twenty":-61.564351,"median":-24.911552,"eighty":-8.688438,"marketCap":72177049159},{"date":"2023-11-24","current":-47.423194,"twenty":-61.037754,"median":-24.911552,"eighty":-8.688438,"marketCap":70722192625},{"date":"2023-12-01","current":-47.541194,"twenty":-60.124403,"median":-24.911552,"eighty":-8.688438,"marketCap":71192149820},{"date":"2023-12-08","current":-43.123442,"twenty":-59.680613,"median":-24.911552,"eighty":-8.688438,"marketCap":64315635348},{"date":"2023-12-15","current":-45.518514,"twenty":-59.330317,"median":-24.911552,"eighty":-8.688438,"marketCap":68279743691},{"date":"2023-12-22","current":-41.339438,"twenty":-58.771185,"median":-24.911552,"eighty":-8.688438,"marketCap":61969530411},{"date":"2023-12-29","current":-45.897864,"twenty":-58.451098,"median":-24.911552,"eighty":-8.688438,"marketCap":69169645563},{"date":"2024-01-05","current":-41.6186,"twenty":-58.024001,"median":-24.911552,"eighty":-8.688438,"marketCap":62278306752},{"date":"2024-01-12","current":-43.437966,"twenty":-57.418459,"median":-24.911552,"eighty":-8.688438,"marketCap":65035419290},{"date":"2024-01-19","current":-39.267262,"twenty":-56.725823,"median":-24.911552,"eighty":-8.688438,"marketCap":58710278761},{"date":"2024-01-26","current":-36.31712,"twenty":-55.836725,"median":-24.911552,"eighty":-8.688438,"marketCap":54088060681},{"date":"2024-02-02","current":-34.853132,"twenty":-55.005219,"median":-24.911552,"eighty":-8.688438,"marketCap":51841523559},{"date":"2024-02-09","current":-39.078682,"twenty":-54.567045,"median":-24.977375,"eighty":-8.690942,"marketCap":58412984292},{"date":"2024-02-16","current":-43.519901,"twenty":-53.86795,"median":-24.961961,"eighty":-8.689273,"marketCap":65065574169},{"date":"2024-02-23","current":-43.423228,"twenty":-53.453001,"median":-24.961961,"eighty":-8.689273,"marketCap":64578799300},{"date":"2024-03-01","current":-43.287126,"twenty":-53.199825,"median":-24.969668,"eighty":-8.690107,"marketCap":64416541010},{"date":"2024-03-08","current":-42.88643,"twenty":-52.44341,"median":-24.969668,"eighty":-8.690107,"marketCap":63848636996},{"date":"2024-03-15","current":-46.524187,"twenty":-51.488905,"median":-25.009567,"eighty":-8.693429,"marketCap":69203160557},{"date":"2024-03-22","current":-52.308694,"twenty":-51.849485,"median":-25.232473,"eighty":-8.716682,"marketCap":58412984292},{"date":"2024-03-28","current":-54.97427,"twenty":-52.93553,"median":-25.488194,"eighty":-8.784794,"marketCap":61171375216},{"date":"2024-04-05","current":-52.146452,"twenty":-52.985136,"median":-25.87886,"eighty":-8.870004,"marketCap":58007338567},{"date":"2024-04-12","current":-54.452719,"twenty":-53.302804,"median":-26.375398,"eighty":-8.942783,"marketCap":60607206202},{"date":"2024-04-19","current":-48.443774,"twenty":-53.302804,"median":-27.157464,"eighty":-9.068996,"marketCap":53873072180},{"date":"2024-04-26","current":-57.196236,"twenty":-53.435518,"median":-27.450523,"eighty":-9.167423,"marketCap":63528035417},{"date":"2024-05-03","current":-59.794233,"twenty":-53.777852,"median":-27.730775,"eighty":-9.397396,"marketCap":66367730487},{"date":"2024-05-10","current":-60.546292,"twenty":-54.435313,"median":-28.113255,"eighty":-9.857114,"marketCap":67362014561},{"date":"2024-05-17","current":-58.658055,"twenty":-54.574873,"median":-28.485417,"eighty":-9.977493,"marketCap":65165427130},{"date":"2024-05-24","current":-52.700238,"twenty":-54.976338,"median":-29.07698,"eighty":-10.139927,"marketCap":58412954655},{"date":"2024-05-31","current":-51.620118,"twenty":-54.976338,"median":-29.361089,"eighty":-10.283386,"marketCap":57273983395},{"date":"2024-06-07","current":-52.565196,"twenty":-54.976338,"median":-30.241673,"eighty":-10.532117,"marketCap":58250244475},{"date":"2024-06-14","current":-56.319381,"twenty":-54.981036,"median":-31.054417,"eighty":-10.718314,"marketCap":62353269027},{"date":"2024-06-21","current":-54.227183,"twenty":-55.099632,"median":-32.881149,"eighty":-10.838576,"marketCap":59911234992},{"date":"2024-06-28","current":-54.249689,"twenty":-55.440028,"median":-33.56094,"eighty":-11.097775,"marketCap":59911234992},{"date":"2024-07-05","current":-58.463788,"twenty":-55.657871,"median":-34.005125,"eighty":-11.220642,"marketCap":64551099658},{"date":"2024-07-12","current":-59.938373,"twenty":-55.745963,"median":-34.181189,"eighty":-11.407271,"marketCap":66276432299},{"date":"2024-07-19","current":-59.716353,"twenty":-55.97848,"median":-34.545269,"eighty":-11.738708,"marketCap":66032170263},{"date":"2024-07-26","current":-57.074426,"twenty":-56.131334,"median":-34.806278,"eighty":-12.250774,"marketCap":63345287873},{"date":"2024-08-02","current":-57.621526,"twenty":-56.307104,"median":-34.994572,"eighty":-12.425719,"marketCap":63915232622},{"date":"2024-08-09","current":-60.772336,"twenty":-56.714024,"median":-35.324454,"eighty":-12.694151,"marketCap":67859465726},{"date":"2024-08-16","current":-59.654815,"twenty":-57.048523,"median":-35.648167,"eighty":-12.850581,"marketCap":66637506560},{"date":"2024-08-23","current":-63.107395,"twenty":-57.458873,"median":-35.962733,"eighty":-13.047453,"marketCap":70792167727},{"date":"2024-08-30","current":-49.12916,"twenty":-57.66299,"median":-36.345755,"eighty":-13.206187,"marketCap":69162888838},{"date":"2024-09-06","current":-49.915263,"twenty":-57.66299,"median":-36.567164,"eighty":-13.37092,"marketCap":70303384060},{"date":"2024-09-13","current":-51.145513,"twenty":-57.66299,"median":-36.671875,"eighty":-13.573848,"marketCap":71847570529},{"date":"2024-09-20","current":-49.167101,"twenty":-57.683721,"median":-36.986342,"eighty":-13.63831,"marketCap":69482554019},{"date":"2024-09-27","current":-53.462204,"twenty":-57.683721,"median":-37.445773,"eighty":-13.783867,"marketCap":76006737495},{"date":"2024-10-04","current":-58.949991,"twenty":-57.776104,"median":-37.558101,"eighty":-13.908798,"marketCap":83427996199},{"date":"2024-10-10","current":-56.643507,"twenty":-57.816343,"median":-37.60917,"eighty":-13.995484,"marketCap":79676590700},{"date":"2024-10-18","current":-54.316933,"twenty":-57.819489,"median":-37.924768,"eighty":-14.224435,"marketCap":75975160467},{"date":"2024-10-25","current":-51.747614,"twenty":-57.819489,"median":-38.255535,"eighty":-14.2894,"marketCap":72376767507},{"date":"2024-11-01","current":-40.961176,"twenty":-57.819489,"median":-38.986697,"eighty":-14.340877,"marketCap":57328942398},{"date":"2024-11-08","current":-45.608937,"twenty":-57.819489,"median":-39.308677,"eighty":-14.420988,"marketCap":63544348421},{"date":"2024-11-15","current":-44.200719,"twenty":-57.819489,"median":-39.497388,"eighty":-14.54548,"marketCap":60930246271},{"date":"2024-11-22","current":-43.988394,"twenty":-57.819489,"median":-39.586206,"eighty":-14.672188,"marketCap":60602664302},{"date":"2024-11-29","current":-45.857239,"twenty":-57.819489,"median":-39.778153,"eighty":-14.785857,"marketCap":63141424563},{"date":"2024-12-06","current":-45.071237,"twenty":-57.819489,"median":-40.220709,"eighty":-14.848685,"marketCap":61912992178},{"date":"2024-12-13","current":-44.682481,"twenty":-57.819489,"median":-40.576246,"eighty":-15.014493,"marketCap":61257828240},{"date":"2024-12-20","current":-42.241276,"twenty":-57.819489,"median":-40.934902,"eighty":-15.254477,"marketCap":57654426579},{"date":"2024-12-27","current":-42.754459,"twenty":-57.819489,"median":-40.969369,"eighty":-15.339213,"marketCap":58309590517},{"date":"2025-01-03","current":-42.534452,"twenty":-57.819489,"median":-41.085429,"eighty":-15.481309,"marketCap":58066335414},{"date":"2025-01-10","current":-40.407856,"twenty":-57.819489,"median":-41.176668,"eighty":-16.193782,"marketCap":54954176393},{"date":"2025-01-17","current":-37.851954,"twenty":-57.819489,"median":-41.179186,"eighty":-16.682563,"marketCap":51519723275},{"date":"2025-01-24","current":-38.69271,"twenty":-57.819489,"median":-41.179186,"eighty":-16.915608,"marketCap":52994055579},{"date":"2025-01-28","current":-39.34211,"twenty":-57.816343,"median":-41.177927,"eighty":-16.989137,"marketCap":54140758482},{"date":"2025-02-07","current":-43.376749,"twenty":-57.822636,"median":-41.225174,"eighty":-17.320246,"marketCap":59382828895},{"date":"2025-02-14","current":-44.895241,"twenty":-57.822636,"median":-41.439791,"eighty":-17.61594,"marketCap":61432031400},{"date":"2025-02-21","current":-49.746076,"twenty":-57.822636,"median":-41.616926,"eighty":-17.999791,"marketCap":68312418916},{"date":"2025-02-28","current":-48.414447,"twenty":-57.822636,"median":-41.739825,"eighty":-18.237812,"marketCap":66264684536},{"date":"2025-03-07","current":-47.922812,"twenty":-57.825782,"median":-42.027254,"eighty":-18.551688,"marketCap":65855137660},{"date":"2025-03-14","current":-48.79914,"twenty":-57.825782,"median":-42.125115,"eighty":-18.662738,"marketCap":67083778288},{"date":"2025-03-21","current":-48.401057,"twenty":-57.825782,"median":-42.299167,"eighty":-18.935846,"marketCap":66510412662},{"date":"2025-03-28","current":-55.188745,"twenty":-57.825782,"median":-42.496478,"eighty":-19.437399,"marketCap":75684262684},{"date":"2025-04-03","current":-812.530138,"twenty":-57.971959,"median":-42.563523,"eighty":-19.437399,"marketCap":82318922076}],"updateTime":1744003710215}}}